Success Metrics

Clinical Success Rate

80.0%

Based on 8 completed trials

Completion Rate

80%(8/10)

Active Trials

1(9%)

Results Posted

13%(1 trials)

Terminated

2(18%)

Phase Distribution

Ph not_applicable

36%

Ph phase_2

18%

Ph phase_3

18%

Ph phase_1

Ph phase_4

18%

Phase Distribution

Early Stage

Mid Stage

Late Stage

Phase Distribution11 total trials

Phase 1Safety & dosage

1(9.1%)

Phase 2Efficacy & side effects

2(18.2%)

Phase 3Large-scale testing

2(18.2%)

Phase 4Post-market surveillance

2(18.2%)

N/ANon-phased studies

4(36.4%)

Highest Phase Reached

Phase 4

Trial Status & Enrollment

Completion Rate

80.0%

8 of 10 finished

Non-Completion Rate

20.0%

2 ended early

Currently Active

trials recruiting

Total Trials

all time

Status Distribution

Active(1)

Completed(8)

Terminated(2)

Detailed Status

Completed8

Terminated2

Recruiting1

Development Timeline

Analytics

Development Status

Total Trials

Active

Success Rate

80.0%

Most Advanced

Phase 4

Trials by Phase

Phase 11 (9.1%)

Phase 22 (18.2%)

Phase 32 (18.2%)

Phase 42 (18.2%)

N/A4 (36.4%)

Trials by Status

terminated218%

completed873%

recruiting19%

Recent Activity

1 active trials

Showing 5 of 11

recruitingnot_applicable

Zn Supplementation in HIV Immunological Non Responders

NCT06612554

terminatednot_applicable

Enteral Zinc to Improve Growth in Infants at Risk for Bronchopulmonary Dysplasia

NCT03532555

completedphase_4

Clinical Trials (11)

Showing 11 of 11 trials

NCT06612554Not Applicable

Zn Supplementation in HIV Immunological Non Responders

Recruiting

NCT03532555Not Applicable

Enteral Zinc to Improve Growth in Infants at Risk for Bronchopulmonary Dysplasia

Terminated

NCT05778383Phase 4

Zinc Supplementation Impact in Acute COVID-19 Clinical Outcomes

Completed

NCT04621149Phase 2

An Outpatient Study Investigating Non-prescription Treatments for COVID-19

Terminated

NCT00981448Not Applicable

Nutrigenomics of Zinc Supplementation in Insulin Secretion and Diabetes

Completed

NCT05095493Not Applicable

Oral Zinc Supplementation to Enhance Botulinum Neurotoxin Response

Completed

NCT02868151Phase 2

Effect of Oral Vitamin C in Assessing the Severity of Oral Mucositis in Chemoradiation of Head and Neck Cancers

Completed

NCT00696410Phase 1

The Impact of Zinc Supplementation on Left Ventricular Function in Nonischemic Cardiomyopathy

Completed

NCT00212368Phase 3

Efficacy and Safety Study of Zinc Acetate to Treat Wilson's Disease in Japan.

Completed

NCT00373100Phase 3

The Efficacy of Zinc as Adjunct Therapy in the Treatment of Severe Pneumonia in Children

Completed

NCT00004338Phase 4

Study of Zinc for Wilson Disease

Completed

All 11 trials loaded

Drug Details

Intervention Type: DIETARY SUPPLEMENT
Total Trials: 11